The abuse liability of nicotine is comparable to or greater than that of a variety of addictive substances. However, the reinforcing and/or rewarding properties of addictive substances other than nicotine far outweigh the reinforcing and/or rewarding effects associated with nicotine use. These data suggest that, in addition to the intrinsic reinforcing effects of nicotine, other factors may contribute to nicotine addiction. One such factor is associative learning, or rather, the ability of nicotine to alter learning and memory processes that may underlie addiction. The present paper presents an overview of the role of learning in nicotine addiction. In addition, recent advances in the identification of behavioral processes, neural substrates, and cellular and molecular substrates that underlie nicotine-associated alterations in learning are reviewed. Particular attention has been paid to research that describes the role of the hippocampus and hippocampusdependent learning processes in nicotine addiction.
Health risks associated with smoking include heart disease, lung disease, stroke [1] , and cancers of the esophagus, lungs, trachea, stomach, cervix, and pancreas [2] . Given the negative effects of smoking on health, it is not surprising that approximately 438,000 smoking-related deaths are reported each year in the United States alone [2] , and nearly one-third of annual cancer-related deaths can be attributed to smoking [2] . Despite the well-known deleterious effects of smoking on health, the Centers for Disease Control reported in 2005 [3] that 20% of adults in the United States are smokers. Reports that 42 .5% of this 20% of adults in the United States attempted to quit during the previous year are encouraging in the face of these grim statistics [3] . However, they also underscore the difficulty of quitting smoking, which can be attributed to the strong addictive effects of nicotine, the primary component in cigarettes that motivates individuals to continue smoking. Furthermore, data indicating that less than 10% of individuals who attempt to quit are successful for one year [4, 5] underscore inadequacies in current smoking cessation therapies.
Like other drugs of abuse, nicotine use produces effects that are both rewarding and reinforcing and produces withdrawal-associated changes in somatic, affective, and cognitive processes [see 6-8 for reviews]. Among the reinforcing effects of the drug are decreased anxiety, enhancements in cognitive processes, and a sense of euphoria [see 8, 9 for reviews]. Attainment of the rewarding properties of nicotine and avoidance of the aversive symptoms associated with withdrawal from nicotine, which include bradycardia, insomnia, gastrointestinal discomfort, increased appetite, cravings, restlessness, irritability, depressed mood, anxiety, and cognitive deficits [10] [11] [12] [13] [14] [15] , are thought to contribute to sustained nicotine use. The importance of alterations in learning, memory, and synaptic plasticity in addiction is an area of increased focus in addiction research, though not a primary focus of many nicotine addiction studies. In a 2005 review [16] , Steven Hyman wrote that, "...addiction represents a pathological usurpation of the neural mechanisms of learning and memory that under normal circumstances serve to shape survival behaviors related to the pursuit of rewards and the cues that predict them", (p. 1414). This statement broadly reflects a growing consensus from numerous laboratories [see [16] [17] [18] [19] [20] [21] for reviews]. Studies have shown that associative and cognitive processes involved in learning are also involved in addiction [see [22] [23] [24] [25] for reviews], that common neural structures are involved in both addiction and learning [26] [27] [28] , and that cell signaling molecules involved in learning [see [29] [30] [31] for reviews] are also involved in addiction [16] [17] [18] [19] . The ability of addictive substances such as nicotine to hijack the neural substrates of learning would explain the ability of these substances to produce long-lasting and maladaptive behavioral and cellular changes that maintain addiction. The present paper presents an overview of the role of learning in nicotine addiction and a review of behavioral processes, neural substrates (with emphasis on the hippocampus), and cellular and molecular substrates that underlie nicotineassociated alterations in learning.
THE ROLE OF LEARNING AND MEMORY IN NICOTINE ADDICTION
Studies and theories have suggested that both reflexive associative learning and cognitively-mediated (i.e., requiring awareness) learning contribute to the development of nicotine addiction [23, 24] . There are multiple ways in which learning-related changes could facilitate the development of addiction. Both reflexive and cognitively mediated associations could form between the rewarding effects of nicotine and environmental stimuli [32-35 and see 22 for review]. Some of these associations can be described in terms of classical conditioning; stimuli that are associated with smoking function as conditioned stimuli (CS), and the reinforcing effects of nicotine, including decreased anxiety and euphoria, function as unconditioned stimuli (US). Once associations are formed between these CSs and USs, subsequent exposure to smoking-related CSs comes to elicit a conditioned response (CR) such as drug-seeking behavior that may ultimately lead to smoking.
In addition to the formation of maladaptive associations that support nicotine addiction, direct effects of nicotine on learning could contribute to nicotine addiction as well [9] . The ability of nicotine to initially enhance some types of learning may in itself be reinforcing. This ability to enhance learning could also contribute to nicotine addiction by facilitating the formation of maladaptive associations, such as drug-context associations, that lead to drug-seeking behavior. Furthermore, effects of nicotine withdrawal on learning may contribute to addiction [9] . Adaptive changes that occur during chronic nicotine administration likely underlie disrupted learning seen during nicotine withdrawal. Relapse could occur in attempts to ameliorate these withdrawalassociated deficits in learning and learning-related processes. In the following sections, we will briefly review evidence supporting the role of these types of learning-related changes in the development and maintenance of nicotine addiction.
Support for the role of associative learning in nicotine addiction has come from studies indicating that increased cravings and physiological responses can be elicited with the presentation of previously neutral stimuli that were paired with smoking [36] . Likewise, withdrawn smokers and smokers who had not abstained from tobacco reported higher levels of craving following the presentation of images of smoking-related stimuli (e.g., a lighter) than following the presentation of non-smoking stimuli [26] [27] [28] (and see [22, 37] for reviews). Further demonstrating the importance of drug-stimulus associations in nicotine addiction, animals increase intravenous self-administration of nicotine when presented with stimuli that were previously paired with nicotine administration [38-40 for reviews] and decrease intravenous self-administration of nicotine in the absence of such conditioned stimuli [33, 40 for reviews]. Thus, formation of drug-stimuli associations and the ability of nicotine to enhance the reinforcing value of nonpharmacologic stimuli [41, 42] may lead to development and maintenance of behaviors that support nicotine addiction.
In addition to the ability of the effects of nicotine to be associated with discrete cues, associations with diffuse contextual cues can also support nicotine addiction. For example, animals will exhibit a preference for a context that was previously paired with nicotine administration [43] [44] [45] [46] . Such data suggest that animals that receive nicotine can form an association between the drug or, rather, the reinforcing effects of the drug and the context in which they received nicotine. In support, a variety of studies have demonstrated that environmental stimuli can both maintain and reinstate drugseeking/drug-taking behavior [32-35, 47, 48 and see 39, 40 for reviews]. Furthermore, contextual cues associated with smoking elicit cravings in smokers [49] [50] [51] . Thus, associations with either discrete stimuli or diffuse contextual stimuli can trigger physiological and behavior responses that can drive nicotine addiction.
Similar to the formation of associations between smoking-related stimuli and the effects of nicotine, direct effects of nicotine on behavioral and neural substrates of learning may contribute to nicotine addiction. These direct effects of nicotine could differentially affect learning as administration shifts from initial (or acute) to chronic administration and then to withdrawn administration. Research suggests that acute nicotine use is associated with the enhancement of learning and memory [see 9, 52-55 for reviews]. This effect of nicotine could reinforce smoking behavior by virtue of the implicit reward associated with enhanced learning and memory. In addition, acute nicotine use could augment the formation of maladaptive associations between smokingrelated stimuli and the rewarding effects of the drug, thereby amplifying the conditioned value of some smoking cues [see 22 for review].
Chronic use, in the case of most drugs of abuse, contributes to addiction by eliciting increased drug consumption in order to overcome the tolerance that develops to the acute rewarding effects of the abused drug following repeated exposure [see 56 for review]. While there is some evidence that tolerance develops to the acute enhancing effect of nicotine on learning and memory as acute nicotine use transitions to chronic use [57, 58] , there is little evidence for a direct role of this behavioral effect in nicotine addiction. Research suggests [see 59 for review] that, rather than increasing nicotine consumption over time, chronic smokers consume the same number of cigarettes each day on average, thereby maintaining a near-constant plasma nicotine level. These data suggest that individuals continue to smoke, not to overcome tolerance, but to avoid the symptoms that characterize the nicotine withdrawal syndrome. Among these symptoms are deficits in learning and memory [14, 57, 60] . Such deficits may also contribute to relapse as individuals who are attempting to quit may smoke again in an effort to ameliorate this effect of nicotine withdrawal.
THE HIPPOCAMPUS: A NEURAL SUBSTRATE FOR NICOTINE ADDICTION?
Studies indicating that the presentation of smokingrelated stimuli to smokers is associated with the activation of brain regions that are involved in addictive processes and learning processes [26-28 and see 22, 37 for reviews] suggest that addiction and learning and memory may share neural substrates. Among the regions that have been identified as potential substrates for both processes are structures that comprise the mesocorticolimbic system, including the nucleus accumbens, the ventral tegmental area, the hippocampus, and the amygdala. Research examining the role of the ventral tegmental area and nucleus accumbens in nicotine addiction indicates that activation of nicotinic acetylcholine receptors (nAChRs) located in the ventral tegmental area results in an increase in dopamine release in the nucleus accumbens [see 61 for review]. Although a number of neurotransmitter systems other than the dopaminergic system may contribute to the rewarding effects of nicotine [see 62 for review], research indicates that this increase in accumbal dopamine release is critical for the rewarding properties of the drug [see 63 for review]. Within this system, it is suggested [64-66 and see 25 for review] that the amygdala and the hippocampus, a structure that is heavily involved in the formation of long-term declarative memories [see 67 for review], function to lay down representations of stimuli (CSs) that are associated with the rewarding effects of nicotine (USs). Subsequent exposure to these CSs comes to elicit a CR (i.e., smoking). Indeed, recent studies indicate that hip-pocampal pathways and amygdalar pathways are critical for cue-elicited drug-seeking/taking [65, 68, 69 and see 70 for review]. The former (i.e., hippocampal pathways) are highly implicated in drug-seeking/taking that is elicited by contextual stimuli. In addition, the role of the hippocampus in strengthening synaptic connections in efferent areas that are also involved in addiction suggest that drug-induced changes in hippocampal function could produce long-lasting functional changes in these areas [20] . These properties of the hippocampus make the hippocampus an intriguing area to study in regards to nicotine addiction.
One behavioral paradigm that has proven useful in examining the role of hippocampus-dependent associations between contextual stimuli and the reinforcing effects of drugs of abuse is context reinstatement. Context reinstatement refers to the ability of contextual stimuli that were previously paired with a discrete cue that signaled drug availability to reinstate drug self-administration [71] . Although limited, there is evidence from research utilizing animals that selfadministration of cocaine, alcohol, and speed-balls and/or drug-seeking can be elicited by exposure to a previously drug-paired (i.e., self-administration trained) context [69, [72] [73] [74] [75] . Furthermore, lesions of the dorsal hippocampus prevent context reinstatement of cocaine administration [69] suggesting a critical role for the structure in context-elicited cocaine use and, perhaps, in context-elicited use of other drugs of abuse.
Support for a role of contextual stimuli in nicotine addiction has come from human research. A number of studies have demonstrated that contextual cues, cues that act as occasion-setters for smoking availability, can elicit nicotine cravings in smokers [49] [50] [51] . Such data suggest that the formation of hippocampus-dependent associations between contextual cues that are related to smoking and the reinforcing effects of nicotine may be important in maintaining smoking behavior and in relapse during periods of abstinence.
The role of the hippocampus in nicotine addiction likely extends beyond its role in the formation of associations between certain types of environmental stimuli (e.g., the smoking context) and the rewarding effects of nicotine. nAChRs in the hippocampus may mediate the direct effects of nicotine on learning and memory. To date, a majority of behavioral research has employed acute nicotine administration to examine the impact of nicotine on hippocampus-dependent forms of learning [see 9, 53-55 for reviews] including avoidance conditioning [76] [77] [78] [79] [80] , delayed matching to sample performance [81, 82] , working memory performance in the radial-arm maze and Morris Water Maze [83] [84] [85] , and contextual and trace fear conditioning [57, [86] [87] [88] [89] [90] [91] [92] [93] [94] [95] . The results overwhelmingly suggest that acute administration of nicotine dose-dependently enhances performance and/or learning of these tasks. Additional support for the role of the hippocampus in the acute effects of nicotine on learning and memory has come from studies indicating that acute nicotine administration alters long term potentiation (LTP), a persistent increase in synaptic strength that is widely considered a mechanism by which learning and memory occurs in the brain [see 96, 97 for reviews]. Briefly, acute nicotine administration decreases the threshold for LTP induction in the hippocampus [98] [99] [100] [101] [102] [103] and can induce hippocampal LTP direcly [104, 105] .
Although numerous paradigms can be used to illustrate the effects of nicotine on hippocampus-dependent learning, the present review will focus on fear conditioning. In fear conditioning, subjects are trained using temporally contiguous pairings of a CS, such as a tone, and an aversive US, such as a footshock. Two associations form as a result of training, an association between the training context and the US (called contextual fear conditioning) and an association between the CS and the US (called cued fear conditioning). The former association requires the hippocampus, while the latter association does not [106] [107] [108] . Fear conditioning has proven to be useful in studying the effects of nicotine on learning and memory for multiple reasons: 1) The task allows researchers to examine two types of learning within one animal: contextual learning and cued learning. 2) Fear conditioning is rapidly acquired; thus, one can easily examine the effects of acute nicotine administration, chronic nicotine administration, and withdrawal from chronic nicotine administration on this type of learning, 3) The neural and molecular substrates of fear conditioning have largely been identified [29 and see 31, 109, 110 for reviews], which facilitates identification of potential biological targets for nicotine that underlie the effects of nicotine on learning.
Previous research indicates that acute nicotine administration enhances contextual fear conditioning [57, [86] [87] [88] [89] [90] [91] [92] [93] [94] [95] . In contrast, chronic administration of a dose of nicotine that produces plasma nicotine levels that are similar to those produced by an acute dose of nicotine that enhances contextual fear conditioning has no effect on the task [57] . These data suggest that behavioral tolerance develops to this effect of acute nicotine with chronic exposure to the drug. Finally, withdrawal from chronic administration of this dose of nicotine is associated with impairments in contextual fear conditioning [57, 86, 111, 112] . Of note, all three patterns of nicotine administration did not affect cued fear conditioning. Thus, only the portion of the fear conditioning task that depends upon the hippocampus [106] [107] [108] is affected by nicotine administration. These results suggest that the effects of nicotine on contextual fear conditioning and, perhaps, learning and memory in general are mediated by nAChRs in the hippocampus and/or a connected structure. However, limited studies have directly assessed the role of hippocampal nAChRs in the acute effects of nicotine on learning [76, 113] , and no studies have examined the role of the hippocampus in the effects of acute, chronic, and withdrawal from chronic nicotine on learning and memory directly until now.
HIPPOCAMPAL nAChR INVOLVEMENT IN THE EFFECTS OF NICOTINE ON LEARNING AND MEMORY
Recent work from our lab has demonstrated that the action of nicotine at dorsal hippocampal nAChRs is sufficient to enhance contextual fear conditioning using direct infusion techniques [114] . In initial experiments, acute nicotine bilaterally infused into the dorsal hippocampus dosedependently enhanced contextual fear conditioning, while nicotine infusions above or below the dorsal hippocampus had no effect on contextual fear conditioning. The latter findings provide strong evidence that the action of the nicotine at dorsal hippocampal nAChRs rather than at nAChRs in surrounding brain regions underlies this effect of the drug on learning. An additional study assessing the effect of acute intrahippocampal nicotine on cued fear conditioning refuted an alternative interpretation of the data positing that the enhancing effects of acute nicotine infusions on contextual fear conditioning reflect alterations in non-associative processes, such as locomotor activity, arousal, or attentional processes rather than alterations in associative contextual learning. If the nicotine produced its effects on contextual fear conditioning via alterations in non-associative processes, then cued fear conditioning should have been similarly impacted by administration of the drug. This result was not seen; conditioning to the CS was unaffected by intrahippocampal nicotine.
Results indicating that acute intrahippocampal nicotine infusions enhanced learning suggest that the effect of chronic nicotine on contextual fear conditioning [57] may also be mediated by nAChRs in the hippocampus. Therefore, to assess the role of hippocampal nAChRs in the effect of chronic nicotine on the task, mice received 14 days of continuous intrahippocampal infusion of a dose of nicotine matched to the acute intrahippocampal dose that had enhanced learning. 1 Mice were trained on the 13 th day and tested on the 14 th day. Consistent with previous results using chronic systemic nicotine administration [57] , chronic intrahippocampal nicotine administration had no effect on contextual conditioning. These data suggest that tolerance may develop to the enhancing effect of acute intrahippocampal nicotine on contextual fear conditioning with chronic exposure to the drug. Furthermore, these data suggest that chronic nicotine exposure alters hippocampal function such that the action of the drug at hippocampal nAChRs no longer produces the same behavioral effect as was seen with acute nicotine infusions. In support, chronic nicotine exposure is associated with prolonged nAChR desensitization and increases in nAChR density in the hippocampus and throughout the brain [e.g., [115] [116] [117] [118] [119] [120] [121] . It is hypothesized that these chronic nicotineassociated neural adaptations and related alterations in second-messenger signaling underlie nicotine withdrawal symptoms during periods of abstinence. Thus, nicotine withdrawal-associated deficits in contextual learning may also be mediated by changes in the hippocampus.
To directly test if the hippocampus is critically involved in withdrawal-associated deficits in contextual fear conditioning, mice treated for 12 days with chronic intrahippocampal infusion of nicotine were withdrawn for twenty-four hours prior to training. 2 As with mice withdrawn for twentyfour hours from chronic systemic nicotine [57] , mice withdrawn from chronic intrahippocampal nicotine demonstrated deficits in contextual fear conditioning. There was no effect of withdrawal from chronic intrahippocampal nicotine on cued fear conditioning, suggesting that withdrawalassociated deficits in contextual fear conditioning reflect alterations in associative learning rather than non-associative processes. In addition, withdrawal from chronic infusion of nicotine into cortical regions above or thalamic regions below the dorsal hippocampus did not alter learning. Taken together, then, the data suggest that chronic nicotine treatment followed by withdrawal from chronic nicotine alters neural function in the dorsal hippocampus leading to deficits in hippocampus-dependent learning and memory. These alterations may occur at the receptor level and/or at the level of second messenger signaling molecules.
HIPPOCAMPAL nAChR SUBTYPE INVOLVEMENT IN THE EFFECTS OF ACUTE, CHRONIC, AND WITHDRAWAL FROM CHRONIC NICOTINE ON LEARNING AND MEMORY
nAChRs are a family of pentameric receptors that are densely located in both the central nervous system and the peripheral nervous system. nAChRs are either homomeric, consisting of ( 2 -10) subunits, or heteromeric, consisting of a combination of and ( 2 -4) subunits [see [122] [123] [124] [125] . A large number of nAChR subtypes have been identified to date. However, two subtypes, the 4 2* nAChRs (* may include additional subunits) and the 7* nAChRs, comprise approximately 90% of nAChRs in the central nervous system [126] [127] [128] [129] [130] . The functional characteristics of these nAChR subtypes differ considerably. For example, 4 2* nAChRs desensitize more slowly than 7* nAChRs and have a higher affinity for both acetylcholine and nicotine than 7* nAChRs [122, 129, 131, 132] . Differences in functional characteristics, localization, and density [127, 129, 131, 133, 134] likely underlie the divergent roles of 4 2* nAChRs and 7* nAChRs in the somatic, affective, and cognitive effects of nicotine. Thus, identifying the role each nAChR subtype plays in the effects of acute nicotine and withdrawal from chronic nicotine on learning and memory should advance understanding of nicotine addiction and aid in development of therapeutics for nicotine addiction.
Although numerous studies have examined if neuronal nAChRs are critically involved in a variety of forms of hippocampus-dependent learning and memory [e.g., 76, 86, [135] [136] [137] , only a few studies have assessed the role of nAChR subtypes in the acute effects of nicotine on learning and memory [86, 87, 95] . To this end, we and others have utilized nAChR subtype selective antagonists [87] and nAChR subunit knockout mice [86, 95] to determine if 4 2* and/or 7* nAChRs are necessary for the enhancing effect of acute nicotine on hippocampus-dependent fear conditioning. Briefly, a study [87] that utilized dihydro-betaerythroidine (DH E), a nAChR antagonist that preferentially binds 4 2* nAChRs, and methyllycaconitine (MLA), a nAChR antagonist that acts preferentially 7* nAChRs, indicated that 4 2* but not 7* nAChRs are critically involved in the enhancing effect of nicotine on hippocampusdependent learning; MLA had no effect, and DH E blocked the enhancing effect of acute nicotine on contextual fear conditioning. Studies demonstrating that acute nicotine fails to enhance hippocampus-dependent fear conditioning in 2 nAChR subunit knockout mice but not 7 nAChR subunit knockout mice provide additional support for this conclusion [86, 95] .
A recent study from our lab [114] extended this conclusion by examining if dorsal hippocampal 4 2* nAChRs and/or 7* nAChRs mediate the effect of acute systemic nicotine on contextual fear conditioning. Specifically, we determined if intrahippocampal infusions of either DH E or MLA would block the enhancing effect of acute systemic nicotine on contextual fear conditioning. Mice receiving intrahippocampal DH E and acute systemic nicotine demonstrated significantly lower levels of contextual conditioning than mice that received intrahippocampal saline and acute systemic nicotine and similar levels of contextual fear conditioning to saline-treated controls. In contrast, mice that received intrahippocampal MLA and acute systemic nicotine demonstrated levels of contextual fear conditioning that were similar to mice that received intrahippocampal saline and acute systemic nicotine. There was no effect of intrahippocampal administration of either antagonist alone on freezing in response to the training context. Thus, the action of nicotine at DH E-sensitive nAChRs but not MLA-sensitive nAChRs in the dorsal hippocampus is necessary for acute nicotine-associated enhancement of contextual fear conditioning.
Just as 2-subunit containing nAChRs are involved in the acute effects of nicotine on contextual learning, these receptors appear to be involved in the effects of withdrawal from nicotine on contextual learning. Previous research suggests that 2 subunit-containing nAChRs are involved in some of the symptoms that characterize nicotine withdrawal, including impaired attention [138] , increases in anxiety [139] , writhing [140] , and anhedonia [141] . In addition, a recent study from our lab has examined the involvement of nAChR subtypes in both spontaneous nicotine withdrawal-associated deficits and nAChR antagonist precipitated withdrawalassociated deficits in learning and memory. Precipitated withdrawal deficits in contextual fear conditioning were evident in mice treated chronically with systemic nicotine for 14 days following a pretraining intraperitoneal injection of DH E but not MLA [111] . Similarly, 2 knockout mice failed to demonstrate nicotine withdrawal-associated deficits in contextual fear conditioning, while 7 knockout mice withdrawn from chronic nicotine administration demonstrated deficits in contextual fear conditioning. Taken together, these data suggest that alterations in 4 2* nAChRs underlie nicotine withdrawal-associated deficits in contextual fear conditioning. However, it is not clear if hippocampal 4 2* nAChRs are the critical population of 4 2* nAChRs through which chronic nicotine exposure and the subsequent removal of nicotine produces its impairing effect on learning and memory. Thus, the role of hippocampal 4 2* nAChRs in the effect of withdrawal from chronic nicotine on contextual fear conditioning was investigated. 3 Mice treated chronically with systemic nicotine or saline for 14 days received a pretraining bilateral infusion of DH E into the dorsal hippocampus. Although intrahippocampal DH E had no effect on contextual fear conditioning in mice treated chronically with systemic saline, intrahippocampal administration of the nAChR antagonist to mice treated chronically with systemic nicotine resulted in deficits in the task. These data suggest that dorsal hippocampal 4 2* nAChRs may be critically involved in nicotine withdrawalassociated deficits in contextual fear conditioning. Furthermore, these data suggest that behavioral tolerance to the enhancing effect of nicotine on contextual conditioning that is seen during chronic nicotine treatment and withdrawalassociated deficits in the task likely reflect alterations in dorsal hippocampal 4 2* nAChRs and/or related cell signaling.
Studies indicating that acute intrahippocampal nicotine enhances [76, 113 and 114] and withdrawal from intrahippocampal nicotine impairs 4 learning and memory suggest that the action of nicotine at hippocampal nAChRs is sufficient to alter associative learning processes. The data reviewed in this section extend these findings by suggesting that the action of nicotine at hippocampal 4 2* nAChRs is not only sufficient, but it is necessary for the effects of nicotine on learning and memory under systemic conditions. In other words, the enhancing effect of nicotine on learning and the impairing effect of nicotine withdrawal on learning requires the action of nicotine at hippocampal 4 2* nAChRs. Identification of nAChR subtypes that are involved in the effects of nicotine will aid in understanding if withdrawal is due to change in receptor function, changes in down-stream cell signaling cascades, or changes in both.
RECEPTOR-LEVEL CORRELATES THAT MAY UN-DERLIE THE EFFECTS OF NICOTINE ON HIPPO-CAMPUS-DEPENDENT LEARNING AND MEMORY
The effects of acute nicotine, chronic nicotine, and withdrawal from chronic nicotine on nAChR function and density have been described previously (see [122, 124, 142, 143] for reviews). Briefly, nAChRs can exist in three functional conformations: closed or inactive, open or active, and desensitized. Binding of agonists, such as endogenous acetylcholine and exogenous nicotine, to closed or inactive nAChRs induces a structural change that causes the ion channel to open. Selected ions, including calcium, enter the cell as a result of this change in the structural conformation of the nAChR, and neurotransmitter release and the activation of second messengers can result [see [144] [145] [146] [147] [148] . Following activation, agonist binding can induce a second conformational change, which leads to desensitization of the receptor. Desensitized receptors bind with higher affinity but are refractory to activation by agonists [143] . Desensitization can either be brief, as is the case with acute nicotine administration, or long-lasting, as is the case with chronic nicotine administration. This long-lasting nAChR desensitization may underlie the increase in nAChR density [116, 120, 149 but see 142] that is seen during and following chronic nicotine exposure [116, [150] [151] [152] [153] [154] [155] [156] [157] [158] [159] .
Research suggests that following a period of chronic nicotine exposure nAChRs can recover function (i.e., can be activated by agonist) in the absence of nicotine [160] . The combined effect of this functional recovery and chronic nicotine-associated increases in nAChR density that persist for up to 8 days in the absence of nicotine [152, 161, 162 and see 142, 143 for reviews] is thought to underlie reported sensitized behavioral and physiological responses to nicotine during nicotine withdrawal [163] [164] [165] [166] [167] . Likewise, these nAChR-level alterations could underlie the aversive effects of nicotine withdrawal and the behavioral effects of nicotine that contribute to dependence [168] .
Alterations in the function and number of nAChRs, specifically hippocampal DH E-sensitive nAChRs, may contribute to the effects of acute nicotine, chronic nicotine, and withdrawal from chronic nicotine on learning and memory. It should be noted, however, that changes in receptor function associated with chronic nicotine treatment may not be the only factor contributing to the behavioral changes seen with chronic nicotine treatment. Specifically, a dissociation between the effects of chronic nicotine treatment on nAChR binding and tolerance has been demonstrated [169] [170] [171] . Tolerance for the acute effects of nicotine on Y-maze locomotor activity and rears was lost after 8 days, tolerance to the acute effects of nicotine on body temperature was lost after 12-16 days, and tolerance to the acute effects of nicotine on heart rate was lost after 20 days [170] . In contrast, nicotine binding returned to control levels after 8 days, and -bungarotoxin binding (i.e., 7* nAChR binding) returned to control levels after only 4 days. Furthermore, the kinetics of nicotine administration altered nAChR binding and influenced the development of tolerance for the effects of nicotine on respiratory rate, acoustic startle response, Y-maze crosses and rears, heart rate, and body temperature; but the relationship between the timing of nicotine delivery and tolerance was opposite of the relationship between delivery timing and nAChR binding [171] . Specifically, mice that received chronic nicotine for 10 days via pulsed delivery showed greater tolerance but less extensive nAChR binding changes than mice that received an identical amount of chronic nicotine but received it continuously. Thus, long-term behavioral changes can be maintained independent of nAChR changes that occur with chronic nicotine treatment. It remains to be seen if the changes that underlie tolerance are the same changes that underlie withdrawal. Nonetheless, these findings suggest that alterations that extend beyond the level of nAChRs, including alterations in cell signaling, may contribute to the long-term effects of nicotine on learning and memory.
SECOND

MESSENGER-LEVEL CORRELATES THAT MAY UNDERLIE THE EFFECTS OF NICO-TINE ON LEARNING AND MEMORY
Although direct evidence supporting a role for alterations in hippocampal cell signaling molecules in the effects of nicotine on hippocampus-dependent learning is limited, recent evidence suggests that acute nicotine administration is associated with increased activation of second messenger signaling molecules and transcription factors, including protein kinase A, ERK, and CREB [98] [99] [100] [101] [102] [103] [104] [105] [172] [173] [174] [175] [176] [177] [178] [179] , that are heavily involved in learning and memory [see 29-31 for reviews]. In addition, a recent study suggests that acute nicotine administration augments learning-related cell signaling in the hippocampus to enhance learning and memory [175] . The researchers demonstrated that systemic administration of a dose of SL327, a drug that inhibits activation of ERK, that did not impair contextual fear conditioning (i.e., a subthreshold dose) blocked the enhancing effect of acute nicotine administration on learning.
Chronic nicotine-associated tolerance and nicotine withdrawal-associated deficits in hippocampus-dependent learning and memory may be associated with concomitant alterations in hippocampal learning-related cell signaling as well. Although the effects of chronic nicotine and withdrawal from chronic nicotine administration on second messenger signaling and gene transcription are not well-studied, there is some evidence to support this hypothesis; in contrast to the effect of acute nicotine on CREB phosphorylation (i.e., acute nicotine-associated increase CREB activation; 178), chronic nicotine exposure may have little effect on phosphorylated CREB levels [180] [181] [182] , and nicotine withdrawal may be associated with decreases in CREB activation [181, 182] .
Like ERK [183] [184] [185] [186] , CREB has been shown to be critically involved in contextual fear conditioning [see 29, [187] [188] [189] . Thus, as tolerance develops for the effects of nicotine on cell signaling molecules and gene transcription factors involved in learning (such as ERK and CREB), tolerance may also develop for the effects of nicotine on learning. Likewise, nicotine withdrawal-associated alterations in behavior such as deficits in learning, which are opposite to the behavioral effects of acute nicotine administration, may reflect alterations in second-messenger signaling and gene transcription that are opposite to those seen with acute nicotine administration. Clearly, research that examines the relationship between changes in cell signaling and changes in learning and memory as nicotine administration transitions from acute to chronic to withdrawal is needed.
SUMMARY
Changes in learning and memory play a central role in nicotine addiction. The effects of nicotine can become associated with discrete cues and contextual cues that can lead to craving and drug-seeking/drug-taking behaviors [68, 69, [72] [73] [74] . In addition, nicotine exerts direct effects of learning that could support nicotine addiction. Previous research indicates that acute nicotine administration enhances, chronic nicotine administration has no effect, and withdrawal from chronic nicotine administration impairs hippocampus-dependent learning and memory [see 9 for review]. Such data suggest that the initial cognitive enhancing effects of nicotine may reinforce nicotine administration, and as tolerance develops, nicotine intake may be maintained to avoid withdrawalassociated cognitive deficits. In addition, individuals who are attempting to quit may begin to smoke again in an effort to ameliorate nicotine withdrawal-associated deficits in learning and memory.
The effects of nicotine on learning and memory are mediated by 4 2* nAChRs in the hippocampus [86, 87, 95 114] 5 and may involve changes in cell signaling molecules that underlie long-term memory [98] [99] [100] [101] [102] [103] [104] [105] [172] [173] [174] [175] [176] [177] [178] [179] . Such data suggest that smoking cessation therapies that target 4 2* nAChRs may be efficacious at ameliorating nicotine withdrawal-associated learning and memory deficits and ameliorating cue-elicited cravings. Indeed, early reports suggest that long-term cessation rates associated with the use of varenicline, a partial 4 2* nAChR agonist and full 7* nAChR agonist [190] that has recently been approved by the Federal Drug Administration for use as a smoking cessation therapy, are significantly greater than long-term cessation rates associated with bupriopion treatment (see [191] for review). Research that further elucidates the role of alterations in nAChRs and cell signaling in the effects of nicotine on learning, memory, and other processes should lead to the development of novel therapeutics for nicotine addiction.
Key Learning Objectives:
Many factors contribute to the development and maintenance of addiction. This review presents an overview of the role of learning and synaptic plasticity in nicotine addiction with emphasis on the behavioral changes that occur with nicotine administration and the underlying neural substrates that contribute to these changes.
Future Research Questions:
Does withdrawal from chronic nicotine produce alterations in learning and memory through changes in receptor function and/or changes in cell signaling cascades? Also, what therapeutic interventions will ameliorate nicotine withdrawal-associated disruption of learning and are these drugs equally effective for other withdrawal symptoms?
